Skip to main content
. 2020 Jun 18;21(12):4337. doi: 10.3390/ijms21124337
AASLD American Association for the Study of Liver Diseases
AE adverse event
ALT alanine aminotransferase
AST aspartate aminotransferase
BMI body mass index
CI confidence interval
CRP C-reactive protein
DLD diabetic liver disease
DPP-4 dipeptidyl peptidase-4
ELF enhanced liver fibrosis
FIB-4 fibrosis-4
HCC hepatocellular carcinoma
HR hazard ratio
JAZF1 juxtaposed with another zinc finger gene 1
MRE magnetic resonance elastography
MRI-PDFF magnetic resonance imaging-proton density fat fraction
NAFLD nonalcoholic fatty liver disease
NASH nonalcoholic steatohepatitis
NAS NAFLD activity score
NFS NAFLD fibrosis score
NIT non-invasive test
OGTT oral glucose tolerance test
OR odds ratio
PNPLA3 patatin-like phospholipase-3
RR risk ratio
SMR standardized mortality rate
T2D type 2 diabetes
TRX thioredoxin